EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Diagnosis and Management of Ocular Graft-Versus-Host Disease at a Tertiary Cancer Center

Eesa M Khattak, Nathan A Seto, Calvin W Wong, Rugveda R Patil, Dan S Gombos iD, Joshua L Olson, Richard W Yee

Journal of Clinical Medicine · 03.03.2026 · 15 (5) · 1926

DOI: 10.3390/jcm15051926 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.03.2026. Verfasst von Eesa M Khattak und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Royal College of Surgeons in Ireland-Bahrain, Muharraq 15503, Bahrain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular graft-versus-host disease (oGVHD) remains one of the most challenging complications of allogeneic hematopoietic stem cell transplantation (HSCT), often leading to severe ocular surface morbidity and irreversible vision loss if not properly managed. Diagnostic uncertainty persists due to variability in clinical presentation and a lack of universally accepted criteria, but the greatest clinical burden lies in establishing effective, durable treatment protocols. Current strategies range from lubricants and topical immunomodulators to advanced surgical interventions; however, outcomes remain inconsistent due to delayed recognition and heterogeneous practices across institutions. At institutions like MD Anderson Cancer Center (MDACC), a structured treatment strategy has been developed that emphasizes early recognition and targeted therapy based on the specific ocular tissues affected. This approach integrates patient-reported outcomes with objective ocular findings and applies stepwise therapeutic escalation aligned with tissue-specific pathology. This review offers a brief overview of the clinical burden and pathophysiology of oGVHD, outlines the key diagnostic challenges, and a more detailed discussion on therapeutic strategies with particular emphasis on the targeted tissue-based approaches.

Schlagwörter

Stichwörter der Autor:innen

allogeneic hematopoietic stem cell transplantchronic graft-versus-host diseasedry eye diseaseocular graft-versus-host diseaseocular surface diseasetissue-based therapy

Autor:innen und Institutionen

  • School of Medicine, Royal College of Surgeons in Ireland-Bahrain, Muharraq 15503, Bahrain.
  • Richard W. Yee, MD PLLC, Houston, TX 77401, USA.
  • Department of Ophthalmology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Department of Biology, Texas A and M University, College Station, TX 77843, USA.
  • Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland.

ORCID-Profile: Dan S Gombos

Zitieren

APA

Khattak, E. M., Seto, N. A., Wong, C. W., Patil, R. R., Gombos, D. S., Olson, J. L., & Yee, R. W. (2026). Current Diagnosis and Management of Ocular Graft-Versus-Host Disease at a Tertiary Cancer Center. Journal of Clinical Medicine, 15(5), 1926. https://doi.org/10.3390/jcm15051926

Vancouver

Khattak EM, Seto NA, Wong CW, Patil RR, Gombos DS, Olson JL, et al. Current Diagnosis and Management of Ocular Graft-Versus-Host Disease at a Tertiary Cancer Center. Journal of Clinical Medicine. 2026;15(5):1926. doi:10.3390/jcm15051926

BibTeX
@article{Khattak2026,
  author = {Khattak, Eesa M and Seto, Nathan A and Wong, Calvin W and Patil, Rugveda R and Gombos, Dan S and Olson, Joshua L and Yee, Richard W},
  title = {Current Diagnosis and Management of Ocular Graft-Versus-Host Disease at a Tertiary Cancer Center},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {1926},
  doi = {10.3390/jcm15051926}
}
Kostenlos starten →